GLP-1 Medications and Thyroid Safety: What Research Shows GLP-1 receptor agonists including semaglutide do not directly alter thyroid hormone production or metabolism in the liver
The STEP (Semaglutide Treatment Effect in People with obesity) trials, which included over 4,500 participants, showed that semaglutide 2.4 mg weekly resulted in mean weight loss of 12.4% to 15.3% of initial body weight over 68 weeks, compared to 2.4% to 3.2% with placebo
Geneva will complete any additional testing needed
These drugs can work through various mechanisms, such as appetite suppression, interference with fat absorption, or altering metabolism
Remy Laser Therapy for Skin Conditions When you develop a fungal infection or plantar wart on your feet, Remy laser therapy may be a superior treatment to provide faster healing
We customize your protocol based on your skins response